[
  {
    "text": "les op\u00e9rateurs de vaccins doivent \u00eatre form\u00e9s de mani\u00e8re ad\u00e9quate \u00e0 la norme OSHA sur les pathog\u00e8nes transmissibles par le sang (29 CFR 1910.1030) et recevoir une formation suppl\u00e9mentaire si n\u00e9cessaire. osha.gov/coronavirus Ce document n'a pas force de loi et n'est en aucun cas destin\u00e9 \u00e0 fonctionner comme un mandat pour le public. Ce document a pour seul but de fournir des \u00e9claircissements au public",
    "identifier": "spanish3512",
    "title": "Consejos de Seguridad para Mantener Seguros a los Trabajadores en los Sitios de Vacunaci\u00f3n Contra el Virus COVID-19",
    "metadata": {
      "file": "/opt/KeyWatch/Web/Archives/MAL/MALADIES-INFECTIEUSES_INFECTIONS-RESPIRATOIRES_2019-nCoV/20211210-14h44/INSTITUTION_US_US-OSHA_COVID-19_NEWS-UPDATES/www.osha.gov/sites/default/files/publications/OSHA4110.pdf",
      "id": "ConsejosdeSeguridadparaMantenerSegurosalosTrabajadoresenlosSitiosdeVacunacionContraelVirusCOVID-19#~#756925#~#www.osha.gov/sites/default/files/publications/OSHA4110.pdf",
      "date-crawl": "2021-12-10 at 14:44:43",
      "url": "/Archives/MAL/MALADIES-INFECTIEUSES_INFECTIONS-RESPIRATOIRES_2019-nCoV/20211210-14h44/INSTITUTION_US_US-OSHA_COVID-19_NEWS-UPDATES/www.osha.gov/sites/default/files/publications/OSHA4110.pdf",
      "url-orig": "https://www.osha.gov/sites/default/files/publications/OSHA4110.pdf",
      "source": "www.osha.gov",
      "date": "10/12/2021",
      "category": "MALADIES-INFECTIEUSES_INFECTIONS-RESPIRATOIRES_2019-nCoV",
      "language": "fr"
    },
    "altTexts": [
      {
        "name": "translation",
        "text": "vaccine operators must be adequately trained in the OSHA Bloodborne Pathogens Standard (29 CFR 1910.1030) and receive additional training as necessary. osha.gov/coronavirus This document does not have the force of law and is in no way intended to function as a mandate to the public. This document is intended solely to provide clarification to the public"
      }
    ],
    "sentences": []
  },
  {
    "text": "les effets sur la sant\u00e9 des programmes de transferts mon\u00e9taires dans les pays \u00e0 revenu faible et interm\u00e9diaire sont particuli\u00e8rement pertinents dans le contexte de la crise \u00e9conomique mondiale actuelle provoqu\u00e9e par COVID-19, qui risque de durer, car ces interventions de lutte contre la pauvret\u00e9 pourraient aider les populations les plus d\u00e9munies, conclut M. Rasella",
    "identifier": "spanish4330",
    "title": "Los programas sociales que transfieren dinero en efectivo pueden disminuir la mortalidad materna",
    "metadata": {
      "file": "/opt/KeyWatch/Web/Archives/MAL/MALADIES-INFECTIEUSES_INFECTIONS-RESPIRATOIRES_2019-nCoV/20210622-07h01/INSTITUTION_ES_BARCELONA-INSTITUTE-OF-GLOBAL-HEALTH_PUBLICATIONS/www.isglobal.org/en/-/s-que-transfieren-dinero-en-efectivo-pueden-disminuir-la-mortalidad-materna.html",
      "id": "Losprogramassocialesquetransfierendineroenefectivopuedendisminuirlamortalidadmaterna-News-ISGLOBAL#~#8700#~#www.isglobal.org/en/-/los-programas-sociales-que-transfieren-dinero-en-efectivo-pueden-disminuir-la-mortalidad-materna",
      "date-crawl": "2021-06-22 at 06:46:12",
      "url": "/Archives/MAL/MALADIES-INFECTIEUSES_INFECTIONS-RESPIRATOIRES_2019-nCoV/20210622-07h01/INSTITUTION_ES_BARCELONA-INSTITUTE-OF-GLOBAL-HEALTH_PUBLICATIONS/www.isglobal.org/en/-/s-que-transfieren-dinero-en-efectivo-pueden-disminuir-la-mortalidad-materna.html",
      "url-orig": "https://www.isglobal.org/en/-/los-programas-sociales-que-transfieren-dinero-en-efectivo-pueden-disminuir-la-mortalidad-materna",
      "source": "www.isglobal.org",
      "date": "22/06/2021",
      "category": "MALADIES-INFECTIEUSES_INFECTIONS-RESPIRATOIRES_2019-nCoV",
      "language": "fr"
    },
    "altTexts": [
      {
        "name": "translation",
        "text": "the health effects of cash transfer programs in low- and middle-income countries are particularly relevant in the context of the current and potentially enduring global economic crisis caused by COVID-19, as these poverty-reduction interventions could help the poorest populations, Rasella concluded"
      }
    ],
    "sentences": []
  },
  {
    "text": "si la personne a r\u00e9pondu OUI \u00e0 la question 5 : si la personne a \u00e9t\u00e9 r\u00e9cemment vaccin\u00e9e, au moins 7 jours doivent s'\u00eatre \u00e9coul\u00e9s depuis pour que la vaccination contre le covid-19 soit pertinente. \u00c0 remplir par le centre de vaccination : Nom du vaccin contre le covid-19 : Dose 1 \u274f Dose 2 \u274f Dose 3 \u274f Num\u00e9ro de lot/lot : Le vaccin a \u00e9t\u00e9 administr\u00e9 dans : le bras droit \u274f le bras gauche \u274f autre, le cas \u00e9ch\u00e9ant",
    "identifier": "swedish1333",
    "title": "Health declaration adult vaccination against COVID-19",
    "metadata": {
      "file": "/opt/KeyWatch/Web/Archives/MAL/MALADIES-INFECTIEUSES_INFECTIONS-RESPIRATOIRES_2019-nCoV/20211013-21h51/INSTITUTION_SE_PUBLIC-HEALTH-AGENCY-OF-SWEDEN_PUBLICATIONS/www.folkhalsomyndigheten.se/contentassets/8366e2718b5d440eabc447fbed23cda1/health-declaration-vaccination-against-covid-19.pdf",
      "id": "HealthdeclarationadultvaccinationagainstCOVID-19#~#119078#~#www.folkhalsomyndigheten.se/contentassets/8366e2718b5d440eabc447fbed23cda1/health-declaration-vaccination-against-covid-19.pdf",
      "date-crawl": "2021-10-13 at 21:51:29",
      "url": "/Archives/MAL/MALADIES-INFECTIEUSES_INFECTIONS-RESPIRATOIRES_2019-nCoV/20211013-21h51/INSTITUTION_SE_PUBLIC-HEALTH-AGENCY-OF-SWEDEN_PUBLICATIONS/www.folkhalsomyndigheten.se/contentassets/8366e2718b5d440eabc447fbed23cda1/health-declaration-vaccination-against-covid-19.pdf",
      "url-orig": "https://www.folkhalsomyndigheten.se/contentassets/8366e2718b5d440eabc447fbed23cda1/health-declaration-vaccination-against-covid-19.pdf",
      "source": "www.folkhalsomyndigheten.se",
      "date": "13/10/2021",
      "category": "MALADIES-INFECTIEUSES_INFECTIONS-RESPIRATOIRES_2019-nCoV",
      "language": "fr"
    },
    "altTexts": [
      {
        "name": "translation",
        "text": "if the person answered YES to question 5: If the person was recently vaccinated, at least 7 days must have passed since then for covid-19 vaccination to be relevant To be completed by the vaccination center: Name of covid-19 vaccine: Dose 1 \u274f Dose 2 \u274f Dose 3 \u274f Lot/batch number: Vaccine was administered in: right arm \u274f left arm \u274f other, if applicable"
      }
    ],
    "sentences": []
  },
  {
    "text": "si la personne a r\u00e9pondu OUI \u00e0 la question 5 : si la personne a \u00e9t\u00e9 r\u00e9cemment vaccin\u00e9e, au moins 7 jours doivent s'\u00eatre \u00e9coul\u00e9s depuis pour que la vaccination par le covid-19 soit envisag\u00e9e. A remplir par le centre de vaccination : Nom du vaccin covid-19 : Dose 1 ' \" Dose 2 ' \" Num\u00e9ro de lot : Le vaccin a \u00e9t\u00e9 administr\u00e9 dans : le bras droit ' \" le bras gauche ' \" Autre site d'administration : Commentaires : Prestataire : Clinique/unit\u00e9 : Nom du vaccinateur : Signature : AUTORIT\u00c9 DE SANT\u00c9 PUBLIQUE, 2021",
    "identifier": "swedish3091",
    "title": "Health declaration adult vaccination against COVID-19",
    "metadata": {
      "file": "/opt/KeyWatch/Web/Archives/MAL/MALADIES-INFECTIEUSES_INFECTIONS-RESPIRATOIRES_2019-nCoV/20210701-19h01/INSTITUTION_SE_PUBLIC-HEALTH-AGENCY-OF-SWEDEN_PUBLICATIONS/www.folkhalsomyndigheten.se/contentassets/8366e2718b5d440eabc447fbed23cda1/health-declaration-adult-vaccination-against-covid-19.pdf",
      "id": "HealthdeclarationadultvaccinationagainstCOVID-19#~#137945#~#www.folkhalsomyndigheten.se/contentassets/8366e2718b5d440eabc447fbed23cda1/health-declaration-adult-vaccination-against-covid-19.pdf",
      "date-crawl": "2021-07-01 at 19:01:11",
      "url": "/Archives/MAL/MALADIES-INFECTIEUSES_INFECTIONS-RESPIRATOIRES_2019-nCoV/20210701-19h01/INSTITUTION_SE_PUBLIC-HEALTH-AGENCY-OF-SWEDEN_PUBLICATIONS/www.folkhalsomyndigheten.se/contentassets/8366e2718b5d440eabc447fbed23cda1/health-declaration-adult-vaccination-against-covid-19.pdf",
      "url-orig": "https://www.folkhalsomyndigheten.se/contentassets/8366e2718b5d440eabc447fbed23cda1/health-declaration-adult-vaccination-against-covid-19.pdf",
      "source": "www.folkhalsomyndigheten.se",
      "date": "01/07/2021",
      "category": "MALADIES-INFECTIEUSES_INFECTIONS-RESPIRATOIRES_2019-nCoV",
      "language": "fr"
    },
    "altTexts": [
      {
        "name": "translation",
        "text": "if the person answered YES to question 5: if the person was recently vaccinated, at least 7 days must have passed since the vaccination for covid-19 to be considered. To be completed by the vaccination center: Name of covid-19 vaccine: Dose 1 ' \" Dose 2 ' \" Lot number: Vaccine was administered in: right arm ' \" left arm ' \" Other site of administration: Comments: Provider: Clinic/unit: Vaccinator's name: Signature: Public Health Authority, 2021"
      }
    ],
    "sentences": []
  },
  {
    "text": "l'EMA a publi\u00e9 de nouvelles mises \u00e0 jour de s\u00e9curit\u00e9 pour Comirnaty, COVID-19 Vaccine Janssen, COVID-19 Vaccine Moderna et Vaxzevria L'EMA a mis \u00e0 jour le guide sur la pr\u00e9paration des plans de gestion des risques pour les vaccins COVID-19",
    "identifier": "english2",
    "title": "COVID-19: latest updates | European Medicines Agency",
    "metadata": {
      "file": "/opt/KeyWatch/Web/Archives/MAL/MALADIES-INFECTIEUSES_INFECTIONS-RESPIRATOIRES_2019-nCoV/20210628-11h44/INSTITUTION_UE_EMA_WHATS-NEW/www.ema.europa.eu/en/human-regulatory/overview/public-health-threats/coronavirus-disease-covid-19/covid-19-latest-updates.html",
      "id": "COVID-19:latestupdatesEuropeanMedicinesAgency#~#310304#~#www.ema.europa.eu/en/human-regulatory/overview/public-health-threats/coronavirus-disease-covid-19/covid-19-latest-updates",
      "date-crawl": "2021-06-28 at 11:36:01",
      "url": "/Archives/MAL/MALADIES-INFECTIEUSES_INFECTIONS-RESPIRATOIRES_2019-nCoV/20210628-11h44/INSTITUTION_UE_EMA_WHATS-NEW/www.ema.europa.eu/en/human-regulatory/overview/public-health-threats/coronavirus-disease-covid-19/covid-19-latest-updates.html",
      "url-orig": "https://www.ema.europa.eu/en/human-regulatory/overview/public-health-threats/coronavirus-disease-covid-19/covid-19-latest-updates",
      "source": "www.ema.europa.eu",
      "date": "28/06/2021",
      "category": "MALADIES-INFECTIEUSES_INFECTIONS-RESPIRATOIRES_2019-nCoV",
      "language": "fr"
    },
    "altTexts": [
      {
        "name": "translation",
        "text": "the EMA has published new safety updates for Comirnaty, COVID-19 Vaccine Janssen, COVID-19 Vaccine Moderna and Vaxzevria The EMA has updated the guidance on the preparation of risk management plans for COVID-19 vaccines"
      }
    ],
    "sentences": []
  },
  {
    "text": "142 nouveaux cas de COVID-19 signal\u00e9s 9 816 nouveaux tests de d\u00e9pistage du COVID-19 ayant donn\u00e9 des r\u00e9sultats",
    "identifier": "english5",
    "title": "Coronavirus (COVID-19): daily data for Scotland - gov.scot",
    "metadata": {
      "file": "/opt/KeyWatch/Web/Archives/MAL/MALADIES-INFECTIEUSES_INFECTIONS-RESPIRATOIRES_2019-nCoV/20210426-20h25/INSTITUTION_UK-SCOTLAND_GOV_HEALTH-AND-SOCIAL-CARE/www.gov.scot/publications/coronavirus-covid-19-daily-data-for-scotland/index.html",
      "id": "CoronavirusCOVID-19:dailydataforScotland-gov.scot#~#48749#~#www.gov.scot/publications/coronavirus-covid-19-daily-data-for-scotland/",
      "date-crawl": "2021-04-26 at 20:22:35",
      "url": "/Archives/MAL/MALADIES-INFECTIEUSES_INFECTIONS-RESPIRATOIRES_2019-nCoV/20210426-20h25/INSTITUTION_UK-SCOTLAND_GOV_HEALTH-AND-SOCIAL-CARE/www.gov.scot/publications/coronavirus-covid-19-daily-data-for-scotland/index.html",
      "url-orig": "https://www.gov.scot/publications/coronavirus-covid-19-daily-data-for-scotland/",
      "source": "www.gov.scot",
      "date": "26/04/2021",
      "category": "MALADIES-INFECTIEUSES_INFECTIONS-RESPIRATOIRES_2019-nCoV",
      "language": "fr"
    },
    "altTexts": [
      {
        "name": "translation",
        "text": "142 new COVID-19 cases reported 9,816 new COVID-19 tests with results"
      }
    ],
    "sentences": []
  },
  {
    "text": "l'ann\u00e9e 2020 restera dans l'histoire comme la premi\u00e8re ann\u00e9e de l'\u00e9pid\u00e9mie du virus SRAS-CoV-2 (coronavirus). Le gouvernement n\u00e9erlandais a pris des mesures pour arr\u00eater la propagation du coronavirus. Il semble que d'autres maladies infectieuses aient \u00e9galement \u00e9t\u00e9 moins r\u00e9pandues en cons\u00e9quence. Par exemple, les maladies infectieuses ont entra\u00een\u00e9 une perte d'ann\u00e9es de vie corrig\u00e9es de l'incapacit\u00e9 (AVCI), \u00e9galement connue sous le nom de charge de morbidit\u00e9. En 2020, le plus grand nombre d'ann\u00e9es de vie en bonne sant\u00e9 a \u00e9t\u00e9 perdu aux Pays-Bas \u00e0 cause de COVID-19 (169 400 AVCI), de la l\u00e9gionellose (6 300 AVCI) et de l'infection grave \u00e0 pneumocoques (6 200 AVCI). Ce top 3 est diff\u00e9rent de celui des ann\u00e9es pr\u00e9c\u00e9dentes en raison de COVID-19. En 2019, il s'agissait de : l'infection grave \u00e0 pneumocoques",
    "identifier": "dutch569",
    "title": "Staat van infectieziekten in Nederland, 2020",
    "metadata": {
      "file": "/opt/KeyWatch/Web/Archives/MAL/MALADIES-INFECTIEUSES_INFECTIONS-RESPIRATOIRES_2019-nCoV/20211213-19h10/INSTITUTION_NL_RIVM_PUBLICATIONS/www.rivm.nl/publicaties/staat-van-infectieziekten-in-nederland-2020.html",
      "id": "StaatvaninfectieziekteninNederland,2020#~#7764#~#www.rivm.nl/publicaties/staat-van-infectieziekten-in-nederland-2020",
      "date-crawl": "2021-12-13 at 19:10:10",
      "url": "/Archives/MAL/MALADIES-INFECTIEUSES_INFECTIONS-RESPIRATOIRES_2019-nCoV/20211213-19h10/INSTITUTION_NL_RIVM_PUBLICATIONS/www.rivm.nl/publicaties/staat-van-infectieziekten-in-nederland-2020.html",
      "url-orig": "https://www.rivm.nl/publicaties/staat-van-infectieziekten-in-nederland-2020",
      "source": "www.rivm.nl",
      "date": "13/12/2021",
      "category": "MALADIES-INFECTIEUSES_INFECTIONS-RESPIRATOIRES_2019-nCoV",
      "language": "fr"
    },
    "altTexts": [
      {
        "name": "translation",
        "text": "l'ann\u00e9e 2020 restera dans l'histoire comme la premi\u00e8re ann\u00e9e de l'\u00e9pid\u00e9mie du virus SRAS-CoV-2 (coronavirus). Le gouvernement n\u00e9erlandais a pris des mesures pour arr\u00eater la propagation du coronavirus. Il semble que d'autres maladies infectieuses aient \u00e9galement \u00e9t\u00e9 moins r\u00e9pandues en cons\u00e9quence. Par exemple, les maladies infectieuses ont entra\u00een\u00e9 une perte d'ann\u00e9es de vie corrig\u00e9es de l'incapacit\u00e9 (AVCI), \u00e9galement connue sous le nom de charge de morbidit\u00e9. En 2020, le plus grand nombre d'ann\u00e9es de vie en bonne sant\u00e9 a \u00e9t\u00e9 perdu aux Pays-Bas \u00e0 cause de COVID-19 (169 400 AVCI), de la l\u00e9gionellose (6 300 AVCI) et de l'infection grave \u00e0 pneumocoques (6 200 AVCI). Ce top 3 est diff\u00e9rent de celui des ann\u00e9es pr\u00e9c\u00e9dentes en raison de COVID-19. En 2019, il s'agissait de : l'infection grave \u00e0 pneumocoques"
      }
    ],
    "sentences": []
  },
  {
    "text": "cela est particuli\u00e8rement vrai pour la coqueluche, les oreillons, les m\u00e9ningocoques, les pneumocoques et la rougeole. Il est probable que cela soit principalement d\u00fb aux mesures introduites en raison de l'\u00e9pid\u00e9mie de coronavirus SRAS-CoV-2, comme le lavage des mains, le maintien de la distance, la fermeture (temporaire) des \u00e9coles et des cr\u00e8ches, la r\u00e9duction du nombre de personnes dans les rassemblements et le nombre maximal de personnes \u00e0 recevoir. L'\u00e9pid\u00e9mie de coronavirus a \u00e9galement eu une incidence sur la mise en \u0153uvre du RVP en 2020. Les vaccinations collectives (pour les enfants \u00e2g\u00e9s de 9 ans et plus) ont d'abord \u00e9t\u00e9 report\u00e9es ou converties en rendez-vous individuels. \u00c0 partir du 1er juillet, le RVP a \u00e9t\u00e9 mis en place",
    "identifier": "dutch1133",
    "title": "Vaccinatiegraad en jaarverslag Rijksvaccinatieprogramma Nederland 2020",
    "metadata": {
      "file": "/opt/KeyWatch/Web/Archives/MAL/MALADIES-INFECTIEUSES_INFECTIONS-RESPIRATOIRES_2019-nCoV/20210705-15h57/INSTITUTION_NL_RIVM_PUBLICATIONS/www.rivm.nl/publicaties/vaccinatiegraad-en-jaarverslag-rijksvaccinatieprogramma-nederland-2020.html",
      "id": "VaccinatiegraadenjaarverslagRijksvaccinatieprogrammaNederland2020RIVM#~#8516#~#www.rivm.nl/publicaties/vaccinatiegraad-en-jaarverslag-rijksvaccinatieprogramma-nederland-2020",
      "date-crawl": "2021-07-05 at 15:57:20",
      "url": "/Archives/MAL/MALADIES-INFECTIEUSES_INFECTIONS-RESPIRATOIRES_2019-nCoV/20210705-15h57/INSTITUTION_NL_RIVM_PUBLICATIONS/www.rivm.nl/publicaties/vaccinatiegraad-en-jaarverslag-rijksvaccinatieprogramma-nederland-2020.html",
      "url-orig": "https://www.rivm.nl/publicaties/vaccinatiegraad-en-jaarverslag-rijksvaccinatieprogramma-nederland-2020",
      "source": "www.rivm.nl",
      "date": "05/07/2021",
      "category": "MALADIES-INFECTIEUSES_INFECTIONS-RESPIRATOIRES_2019-nCoV",
      "language": "fr"
    },
    "altTexts": [
      {
        "name": "translation",
        "text": "this is particularly true for pertussis, mumps, meningococcal, pneumococcal, and measles. It is likely that this is primarily due to measures introduced because of the SARS-CoV-2 outbreak, such as handwashing, maintaining distance, (temporary) closure of schools and day care centers, reducing the number of people in gatherings, and the maximum number of people to be received. The coronavirus outbreak also impacted the implementation of the VPN in 2020. Group immunizations (for children aged 9 and older) were initially postponed, or converted to individual appointments. Beginning on July 1, VPN has been implemented"
      }
    ],
    "sentences": []
  },
  {
    "text": "le directeur par int\u00e9rim de l'EU-OSHA, William Cockburn, donne une vue d'ensemble des risques \u00e9mergents, tandis que d'autres coll\u00e8gues mettent en \u00e9vidence la persistance de la pand\u00e9mie et donnent des conseils sur le retour au travail",
    "identifier": "danish6948",
    "title": "H\u00f8jdepunkter | Safety and health at work EU-OSHA",
    "metadata": {
      "file": "/opt/KeyWatch/Web/Archives/MAL/MALADIES-INFECTIEUSES_INFECTIONS-RESPIRATOIRES_2019-nCoV/20211214-07h16/INSTITUTION_UE_EU-OSHA/osha.europa.eu/da/highlights.html",
      "id": "HojdepunkterSafetyandhealthatworkEU-OSHA#~#124011#~#osha.europa.eu/da/highlights",
      "date-crawl": "2021-12-14 at 07:14:23",
      "url": "/Archives/MAL/MALADIES-INFECTIEUSES_INFECTIONS-RESPIRATOIRES_2019-nCoV/20211214-07h16/INSTITUTION_UE_EU-OSHA/osha.europa.eu/da/highlights.html",
      "url-orig": "https://osha.europa.eu/da/highlights",
      "source": "osha.europa.eu",
      "date": "14/12/2021",
      "category": "MALADIES-INFECTIEUSES_INFECTIONS-RESPIRATOIRES_2019-nCoV",
      "language": "fr"
    },
    "altTexts": [
      {
        "name": "translation",
        "text": "eU-OSHA Acting Director William Cockburn provides an overview of emerging risks, while other colleagues highlight the persistence of the pandemic and offer advice on returning to work"
      }
    ],
    "sentences": []
  },
  {
    "text": "avec la fin de la pand\u00e9mie de COVID-19, il semble que le t\u00e9l\u00e9travail va continuer \u00e0 \u00eatre utilis\u00e9, mais que peuvent nous apprendre les entreprises qui utilisaient d\u00e9j\u00e0 le t\u00e9l\u00e9travail avant la pand\u00e9mie sur la fa\u00e7on de s'assurer que",
    "identifier": "czech5265",
    "title": "Hlavn\u00ed zpr\u00e1vy | Safety and health at work EU-OSHA",
    "metadata": {
      "file": "/opt/KeyWatch/Web/Archives/MAL/MALADIES-INFECTIEUSES_INFECTIONS-RESPIRATOIRES_2019-nCoV/20211116-06h45/INSTITUTION_UE_EU-OSHA/osha.europa.eu/cs/highlights.html",
      "id": "HlavnizpravySafetyandhealthatworkEU-OSHA#~#122694#~#osha.europa.eu/cs/highlights",
      "date-crawl": "2021-11-16 at 06:43:15",
      "url": "/Archives/MAL/MALADIES-INFECTIEUSES_INFECTIONS-RESPIRATOIRES_2019-nCoV/20211116-06h45/INSTITUTION_UE_EU-OSHA/osha.europa.eu/cs/highlights.html",
      "url-orig": "https://osha.europa.eu/cs/highlights",
      "source": "osha.europa.eu",
      "date": "16/11/2021",
      "category": "MALADIES-INFECTIEUSES_INFECTIONS-RESPIRATOIRES_2019-nCoV",
      "language": "fr"
    },
    "altTexts": [
      {
        "name": "translation",
        "text": "with the end of the COVID-19 pandemic, it appears that telecommuting will continue to be used, but what can we learn from companies that were already using telecommuting before the pandemic about how to ensure that"
      }
    ],
    "sentences": []
  },
  {
    "text": "cOVID-19, t\u00e9l\u00e9travail et s\u00e9curit\u00e9 et sant\u00e9 au travail : quelles le\u00e7ons avons-nous tir\u00e9es ? \u00c0 la lumi\u00e8re de l'augmentation consid\u00e9rable du t\u00e9l\u00e9travail caus\u00e9e par la pand\u00e9mie de COVID-19, de nombreux travailleurs continuant \u00e0 travailler \u00e0 domicile, un nouveau rapport examine les risques associ\u00e9s en mati\u00e8re de s\u00e9curit\u00e9 et de sant\u00e9. Il comprend des entretiens approfondis avec des travailleurs",
    "identifier": "czech5395",
    "title": "Hlavn\u00ed zpr\u00e1vy | Safety and health at work EU-OSHA",
    "metadata": {
      "file": "/opt/KeyWatch/Web/Archives/MAL/MALADIES-INFECTIEUSES_INFECTIONS-RESPIRATOIRES_2019-nCoV/20211128-07h01/INSTITUTION_UE_EU-OSHA/osha.europa.eu/cs/highlights.html",
      "id": "HlavnizpravySafetyandhealthatworkEU-OSHA#~#123448#~#osha.europa.eu/cs/highlights",
      "date-crawl": "2021-11-28 at 06:59:15",
      "url": "/Archives/MAL/MALADIES-INFECTIEUSES_INFECTIONS-RESPIRATOIRES_2019-nCoV/20211128-07h01/INSTITUTION_UE_EU-OSHA/osha.europa.eu/cs/highlights.html",
      "url-orig": "https://osha.europa.eu/cs/highlights",
      "source": "osha.europa.eu",
      "date": "28/11/2021",
      "category": "MALADIES-INFECTIEUSES_INFECTIONS-RESPIRATOIRES_2019-nCoV",
      "language": "fr"
    },
    "altTexts": [
      {
        "name": "translation",
        "text": "cOVID-19, telecommuting and occupational safety and health: what lessons have we learned? In light of the dramatic increase in telecommuting caused by the COVID-19 pandemic, with many workers continuing to work from home, a new report examines the associated safety and health risks. It includes in-depth interviews with workers"
      }
    ],
    "sentences": []
  }
]
